Persistent effect of tocilizumab in refractory Takayasu’s arteritis (clinical observation)
Study of the interleukin 6 (IL-6) role in chronic autoimmune inflammation has led to the development of innovative treatments for various autoimmune inflammatory rheumatic diseases, including Takayasu’s arteritis (TAK). Given the important role of IL-6 in the pathogenesis of TAK and its association...
Saved in:
| Main Authors: | G. M. Koilubaeva, A. Sh. Sarybaev, A. M. Bolotbekova, T. V. Dubinina, E. L. Nasonov, F. S. Dzhuzenova, M. A. Chukubaev, Z. E. Turdukulov, K. A. Dzhailobaeva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA PRESS LLC
2022-05-01
|
| Series: | Научно-практическая ревматология |
| Subjects: | |
| Online Access: | https://rsp.mediar-press.net/rsp/article/view/3158 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
INNOVATIVE TREATMENTS FOR TAKAYASU’S ARTERITIS: A FOCUS ON INTERLEUKIN-6 INHIBITORS. THE AUTHORS’ EXPERIENCE WITH TOCILIZUMAB AND A REVIEW OF LITERATURE
by: T. V. Beketova, et al.
Published: (2017-10-01) -
Difficulties in the Diagnosis and Management of Patients with Takayasu’s Arteritis: A Description of a 5-Year Clinical Follow-Up
by: A. V. Petrov, et al.
Published: (2023-10-01) -
The efficacy of interleukin-6 inhibitor tocilizumab for takayasu’s arteritis, after insufficient response to previous treatment with glucocorticoids, methotrexate, cyclophosphamide, fludarabine. (A case report)
by: V. N. Antipova, et al.
Published: (2021-01-01) -
Tocilizumab in Extracranial Giant-Cell Arteritis and Takayasu Arteritis: A Multicentric Observational Comparative Study
by: Carmen Lasa-Teja, et al.
Published: (2025-01-01) -
Anesthetic Management of Parturients with Takayasu’s Arteritis: A Series of Three Cases
by: Nilesh M. Solanki, et al.
Published: (2025-01-01)